Description: Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.
Home Page: www.wondfo.com.cn
No.8 Lizhishan Road
Guangzhou,
China
Phone:
86 40 0830 8768
Officers
| Name | Title |
|---|---|
| Mr. Wen Mei Li | MD & Director |
| Ms. Fang Xia Yu | CFO & Deputy GM |
| Ms. Ke Ren Kang | Deputy Gen. Mang. |
| Mr. Zhongxiong Peng | Deputy GM & Director |
| Yaping Zhao | Deputy Gen. Mang. |
| Ms. Tong Zhang | Deputy Gen. Mang. |
| Ms. Hong Hu | Board Sec. |
| Mr. Hong Luo | Deputy Gen. Mang. and Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 11.0957 |
| Price-to-Book MRQ: | 4.8448 |
| Price-to-Sales TTM: | 3.4622 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3411 |